Mass General Cancer Center shared a post on X:
“A study led by researchers at Mass General Cancer Center found that an individualized cancer therapy tailored to the unique tumor profiles of patients with melanoma and lung cancer was well-tolerated and boosted immune activity.”
Individualized Cancer Therapy Demonstrates Safety and Sustained Immune Responses published in Massachusetts General Hospital.
